Henshaw Capital’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Henshaw Capital's HALO Position: Q4 2025 in Review
Henshaw Capital sold out of Halozyme (HALO) in Q4 2025, closing a stake of 6,836 shares — an estimated $501K sold.
Henshaw Capital first reported a position in HALO in Q3 2020 and held it in 21 quarters. The position peaked at $1.1M in Q1 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.
- Henshaw Capital reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
- Henshaw Capital sold 6,836 Halozyme shares in Q4 2025, an estimated $501K.
- Henshaw Capital first reported a position in Halozyme in Q3 2020 and held it in 21 quarters.
- Henshaw Capital's Halozyme position peaked at $1.1M in Q1 2025.
- 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.
Based on Henshaw Capital's 13F filing for Q4 2025, filed 28 May 2026.